10 visits | 40 weeks
During these visits, study participants will receive their assigned study drug (investigational drug or placebo). In addition, the study doctor will continue to conduct study-related tests, assessments, and procedures to monitor the health of study participants and to gather data to help determine the effects (if any) of the investigational drug.